Advancements in adenoviral based virotherapy for ovarian cancer

Kellie S Matthews1, Ronald D Alvarez, David T Curiel

  • 1The Division of Gynecologic Oncology, The University of Alabama at Birmingham, 619 19th Street South, OHB 534, Birmingham, AL 35213, USA. ksmatthews13@gmail.com

Insights

Virotherapy shows promise for treating ovarian cancer, a deadly gynecologic malignancy. Adenoviruses are effective vectors for delivering this novel treatment, potentially improving patient survival rates.

Area of Science:

  • Gynecologic Oncology
  • Viral Oncology
  • Gene Therapy

Background:

  • Ovarian cancer presents poor survival outcomes, necessitating novel therapeutic strategies.
  • Current treatments for ovarian cancer are limited, highlighting the need for innovative approaches.
  • Virotherapy offers a potential new avenue for improving ovarian cancer patient survival.

Purpose of the Study:

  • To review advancements in virotherapy for ovarian cancer treatment.
  • To highlight the potential of adenoviral vectors in ovarian cancer virotherapy.
  • To discuss the advantages of adenoviruses as vectors in cancer treatment.

Main Methods:

  • Literature review of virotherapy research in ovarian cancer.
  • Focus on adenoviral vector applications and characteristics.
  • Analysis of current and emerging virotherapy strategies.

Main Results:

  • Adenoviruses possess advantageous properties for virotherapy, including a well-defined structure.
  • Adenoviruses demonstrate efficient cellular infection capabilities, crucial for oncolytic activity.
  • Virotherapy research is progressing, with adenoviral vectors showing significant promise.

Conclusions:

  • Virotherapy, particularly using adenoviral vectors, represents a promising frontier in ovarian cancer treatment.
  • The unique properties of adenoviruses make them suitable candidates for developing effective ovarian cancer virotherapies.
  • Further research into adenoviral virotherapy could lead to improved outcomes for ovarian cancer patients.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...